Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2022 | Addressing disparities seen in care between black and white patients with DLBCL

Daniel Arthur Ermann • 4 Jun 2022
ASCO 2022
Diffuse Large B-Cell Lymphoma Non-Hodgkin Lymphoma

Daniel Arthur Ermann, MD, Huntsman Cancer Institute, University of Utah, UT, discusses strategies to address healthcare disparities seen in care between black and white patients with diffuse large B-cell lymphoma (DLBCL). This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.

More from Daniel Arthur Ermann

3:53
Racial disparities affecting black patients with diffuse large B-cell lymphoma
Daniel Arthur Ermann • 4 Jun 2022

Related Videos

3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
1:37
Exciting CAR-T clinical trials in LBCL and FL
Gloria Iacoboni • 15 Apr 2024
1:48
Novel immunotherapy approaches in lymphoma: CAR-T cells, bispecifics & sequencing
Gloria Iacoboni • 15 Apr 2024
2:09
Using lineage tracing to define responding CAR T-cells in patients with LBCL
Zinaida Good • 9 Apr 2024
The content of VJHemOnc is intended for healthcare professionals